Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
PBF Energy Inc. (PBF) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PBF Energy Inc. (PBF) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for October 11th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 11th:
PBF Energy Inc. (PBF - Free Report) : This company that engages in refining and supplying petroleum products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.6% over the last 60 days.
PBF Energy Inc. Price and Consensus
PBF Energy Inc. price-consensus-chart | PBF Energy Inc. Quote
PBF’ shares gained 14.7% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of A.
PBF Energy Inc. Price
PBF Energy Inc. price | PBF Energy Inc. Quote
Praxis Precision Medicines, Inc. (PRAX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 15% over the last 60 days.
Praxis Precision Medicines, Inc. Price and Consensus
Praxis Precision Medicines, Inc. price-consensus-chart | Praxis Precision Medicines, Inc. Quote
Praxis’s shares gained 9.2% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of A.
Praxis Precision Medicines, Inc. Price
Praxis Precision Medicines, Inc. price | Praxis Precision Medicines, Inc. Quote
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote
Catalyst’s shares gained 0.8% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of B.
Catalyst Pharmaceuticals, Inc. Price
Catalyst Pharmaceuticals, Inc. price | Catalyst Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.